AR011134A1 - Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento - Google Patents

Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento

Info

Publication number
AR011134A1
AR011134A1 ARP980100614A ARP980100614A AR011134A1 AR 011134 A1 AR011134 A1 AR 011134A1 AR P980100614 A ARP980100614 A AR P980100614A AR P980100614 A ARP980100614 A AR P980100614A AR 011134 A1 AR011134 A1 AR 011134A1
Authority
AR
Argentina
Prior art keywords
salt
procedure
manufacture
compound
preparation
Prior art date
Application number
ARP980100614A
Other languages
English (en)
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR011134A1 publication Critical patent/AR011134A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980100614A 1997-02-25 1998-02-11 Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento AR011134A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Publications (1)

Publication Number Publication Date
AR011134A1 true AR011134A1 (es) 2000-08-02

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100614A AR011134A1 (es) 1997-02-25 1998-02-11 Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento

Country Status (32)

Country Link
US (1) US6265415B1 (enExample)
EP (1) EP0971920B1 (enExample)
JP (1) JP2001512477A (enExample)
KR (1) KR20000075622A (enExample)
CN (1) CN1100056C (enExample)
AR (1) AR011134A1 (enExample)
AT (1) ATE218569T1 (enExample)
AU (1) AU723389B2 (enExample)
BR (1) BR9807457A (enExample)
CA (1) CA2280008A1 (enExample)
CZ (1) CZ291681B6 (enExample)
DE (1) DE69805787T2 (enExample)
DK (1) DK0971920T3 (enExample)
EE (1) EE04016B1 (enExample)
ES (1) ES2178169T3 (enExample)
HU (1) HUP0000720A3 (enExample)
ID (1) ID22218A (enExample)
IL (1) IL131122A0 (enExample)
IS (1) IS1901B (enExample)
MY (1) MY118822A (enExample)
NO (1) NO313009B1 (enExample)
NZ (1) NZ336878A (enExample)
PL (1) PL190379B1 (enExample)
PT (1) PT971920E (enExample)
RU (1) RU2193036C2 (enExample)
SE (1) SE9700661D0 (enExample)
SK (1) SK283903B6 (enExample)
TR (1) TR199902060T2 (enExample)
TW (1) TW568907B (enExample)
UA (1) UA64741C2 (enExample)
WO (1) WO1998037080A1 (enExample)
ZA (1) ZA981134B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
EP0909323B1 (en) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2004026867A2 (en) 2002-09-19 2004-04-01 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
JP4977465B2 (ja) * 2004-07-28 2012-07-18 武田薬品工業株式会社 ピロロ［２，３−ｃ］ピリジン化合物、その製造方法および用途
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
DK1784402T3 (da) 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
PT1963302E (pt) 2005-12-05 2013-04-09 Pfizer Prod Inc Polimorfos de um inibidor de c-met/hgfr
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
IN2012DN04917A (enExample) * 2009-11-05 2015-09-25 Univ Notre Dame Du Lac
EP2716642B1 (en) 2011-05-30 2016-07-20 Astellas Pharma Inc. Imidazopyridine compound
EP2927231B1 (en) * 2012-11-30 2017-09-20 Astellas Pharma Inc. Imidazopyridine compounds
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
CA2280008A1 (en) 1998-08-27
CZ301499A3 (cs) 2000-02-16
RU2193036C2 (ru) 2002-11-20
DK0971920T3 (da) 2002-09-16
CN1100056C (zh) 2003-01-29
PL335485A1 (en) 2000-04-25
KR20000075622A (ko) 2000-12-26
IS5148A (is) 1999-08-05
IS1901B (is) 2003-11-20
CZ291681B6 (cs) 2003-04-16
EE9900367A (et) 2000-04-17
DE69805787T2 (de) 2003-01-02
ID22218A (id) 1999-09-16
WO1998037080A1 (en) 1998-08-27
SE9700661D0 (sv) 1997-02-25
IL131122A0 (en) 2001-01-28
UA64741C2 (uk) 2004-03-15
DE69805787D1 (de) 2002-07-11
ZA981134B (en) 1998-08-25
HUP0000720A2 (hu) 2000-10-28
ATE218569T1 (de) 2002-06-15
PT971920E (pt) 2002-11-29
SK109999A3 (en) 2000-01-18
ES2178169T3 (es) 2002-12-16
US6265415B1 (en) 2001-07-24
JP2001512477A (ja) 2001-08-21
MY118822A (en) 2005-01-31
BR9807457A (pt) 2000-04-25
CN1248257A (zh) 2000-03-22
NO994078D0 (no) 1999-08-24
AU6314798A (en) 1998-09-09
PL190379B1 (pl) 2005-12-30
TR199902060T2 (xx) 2000-02-21
SK283903B6 (sk) 2004-04-06
NO313009B1 (no) 2002-07-29
HK1024248A1 (en) 2000-10-05
NZ336878A (en) 2001-05-25
EP0971920B1 (en) 2002-06-05
MX9907650A (es) 2002-12-13
AU723389B2 (en) 2000-08-24
EP0971920A1 (en) 2000-01-19
TW568907B (en) 2004-01-01
NO994078L (no) 1999-08-24
HUP0000720A3 (en) 2001-01-29
EE04016B1 (et) 2003-04-15

Similar Documents

Publication Publication Date Title
AR015769A1 (es) Derivados de imidazo piridina que inhiben la secrecion de acido gastrico, procedimiento para la preparacion de dichos derivados, composicion farmaceutica, uso de dichos derivados para la preparacion de medicamentos, y compuestos intermediarios.
AR015157A1 (es) DERIVADOS DEL ÁCIDO 5-ALQUIL-2-ARILAMINOFENILÁCETICO, COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE, SU USO EN LA MANUFACTURA DE UN MEDICAMENTO Y MÉTODO DE PREPARACIoN DEL MISMO
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
SE8804629D0 (sv) New therapeutically active compounds
ATE73776T1 (de) 4-aminochinolin-derivate und ihre verwendung als arzneimittel.
SE8700499D0 (sv) Novel pharmacologically active compounds
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
AR007352A1 (es) Derivados sustituidos de bencimidazol, proceso para su preparacion, formulacion farmaceutica que los contiene, y uso de dichos derivados para la manufactura de medicamentos
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
FI963885A0 (fi) Pyrimidiini- tai triatsiinikarboksyylihappojohdannaiset käytettäväksi lääkaineina
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
SE8700714D0 (sv) Anvendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat for framstellning av lekemedel for behandling av sjukdomar i matsmeltningskanalen och som antiulcerost lekemedel
UY26211A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo (2.2.2)oct-3-ilamina y sus composiciones farmaceuticas
NO165195C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler.
NO950177L (no) Farmakologisk aktive erivater
ES2138226T3 (es) Derivados del acido imidazo(1,2-a)indeno(1,2-e)pirazina-2-carboxilico, su preparacion y los medicamentos que les contienen.
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
GT200000087A (es) Formas polimorfas de un citrato de azabiciclo(2.2.2) octan - 3 - amina y sus composiciones farmaceuticas.
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
MX9205204A (es) Composicion farmaceutica que comprende compuestos antagonistas del receptor 5-hidroxitriptamina
UY26381A1 (es) Derivados de ter-butil-(7-metil-imidazo 1.2-a piridin-3-il)-amina. procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de no-sintasa y composiciones farmaceuticas que los

Legal Events

Date Code Title Description
FG Grant, registration